Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.
about
Pros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesVisualization of DC-SIGN-mediated entry pathway of engineered lentiviral vectors in target cellsProduction of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells.Targeting the tumor microenvironment to enhance antitumor immune responsesProphylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic CellsDevelopment of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells.Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD miceHuman parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription.Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.Personalized dendritic cell-based tumor immunotherapy.Dendritic cell-based vaccines for the therapy of experimental tumors.Engineering dendritic cells to enhance cancer immunotherapy.Cell-based drug-delivery platforms.Targeting lentiviral vectors for cancer immunotherapy.mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugsmRNA-based dendritic cell vaccines.Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cellsExpression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses.Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB.Targeted gene therapy of autoimmune diseases: advances and prospects.Lentivectors are efficient tools to manipulate the dendritic cell cytoskeleton.Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma.Direct and indirect antitumor effects by human peripheral blood lymphocytes expressing both chimeric immune receptor and interleukin-2 in ovarian cancer xenograft model.The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
P2860
Q27013679-1BE3CBFB-090E-49DC-9C6E-899433679653Q28534404-830C5BB6-96EA-4858-A85E-A5B41AE4CBF3Q34576498-7EE059CF-5DD2-4EA4-A8F9-F92D608A7C0FQ35176307-196EACEF-7DB5-4B09-8812-5C4BE6418BCFQ35761001-ECB7157C-F301-4A7C-A1BA-A38F14BF1AABQ36168490-76EE3957-1008-4B71-8F00-6873ABB6CF3FQ36460535-8D443D0E-F99F-4697-9FE5-E19A7677FA63Q36755359-F23AA2D9-CF6E-41F3-9F61-F46138274BC9Q37035660-F61D79A8-E043-4F5C-95B7-DF20F8E79F63Q37621566-9FE20433-8AC4-4C04-A4F9-9D951F257956Q37693733-FAB30E0D-76ED-4B89-9A34-A2EB8DA8B959Q37773259-689FAC77-AA0B-4846-A034-5F3C34C68F4EQ37862064-BCF2CFB7-A969-48B3-A0ED-0ED85E9FAD5DQ38029631-5B7293DD-12AB-4AE2-9C6B-FAAE0086DFB3Q38043924-B5D7C9CF-68AC-4436-BF6B-FF45B229D755Q38071900-BFB7BF22-4DBD-4B25-B284-362B60244071Q38199151-063D66E1-D460-4855-9A98-E687587E574AQ38206520-4878628F-1A1E-4977-9E3C-80B61B1AB9B9Q38246769-1C97BC84-8AB4-4337-9DA9-F8DE341F87B5Q41869921-24254A12-169B-47A5-8B62-7F19D0336A92Q41952315-E4F686BF-4E80-437F-878E-D82748E22002Q41959409-8C8EC3FA-CD85-4655-AC09-DFC520ABECDCQ45859107-62E9C285-AD39-435A-87E1-F67DB006CD50Q45871804-46934DF2-F11C-448F-9352-2F3ED6E43AE0Q45882718-5CC9E888-FFF8-4978-9E92-263BFD01A182Q49715007-E499D471-F436-4615-9E4D-7F8685E6069EQ54667188-6FC960B8-3C94-4A25-A066-89965AE306F1Q58750585-C0118C02-6D63-498C-82BD-1157709EF426
P2860
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Exploiting dendritic cells for ...... dification of dendritic cells.
@ast
Exploiting dendritic cells for ...... dification of dendritic cells.
@en
type
label
Exploiting dendritic cells for ...... dification of dendritic cells.
@ast
Exploiting dendritic cells for ...... dification of dendritic cells.
@en
prefLabel
Exploiting dendritic cells for ...... dification of dendritic cells.
@ast
Exploiting dendritic cells for ...... dification of dendritic cells.
@en
P2093
P2860
P356
P1476
Exploiting dendritic cells for ...... dification of dendritic cells.
@en
P2093
Bart Neyns
Carlo Heirman
Karine Breckpot
Kris Thielemans
P2860
P304
P356
10.1002/JGM.615
P577
2004-11-01T00:00:00Z